All regulatory communications have data.
Successful communications have a story.
Work with 3D to get your story straight from the start.
Strengthen your responses and expand your discussions with
CHMP to resolve issues blocking your product’s authorization.
Understand the CHMP’s underlying concerns behind their questions and objections.
Tackle their scientific and regulatory concerns head-on.
Expand your messages and supporting data to highlight your product’s benefit.
That’s where 3D comes in. 3D helps you
-
Leverage Day 120 / 180 requests, Joint Assessment Reports, and regulatory precedent to guide your response strategy.
-
Craft clear, consistent responses and integrate key messages and relevant data into meeting scripts.
-
Prepare for tough questions with tailored mock sessions and focused rehearsals.
We work with you to maximize every CHMP interaction—so your messages gain momentum towards authorization.
Our Latest Thinking
- The FDA Advisory Committee Survival Manual
- Taking a Strategic Approach Early to Overcome Regulatory Hurdles and Win Approval
- Pink Sheet: Advisory Committee Disagreement With US FDA On Approval Decisions An Increasingly Rare Event
Our proven process 3D ACT® is not magic. It's better.
Learn Why